Sharechat Logo

Trilogy flags return to profit in first half on Australian sales

Thursday 18th September 2014

Text too small?

Trilogy International, the skincare and scented candle company, expects to return to profit in the first half of its financial year as Australian sales pick up.

Net profit is expected to be $860,000 in the six months ending Sept. 30, from a loss of $269,000 a year earlier, the Auckland-based company said in a statement. Sales will rise 11 percent to $15 million, it said.

The company, which is 49 percent owned by The Bakery Business, changed its name from Ecoya to Trilogy in June last year to reflect the growing dominance of the skincare brand. Ecoya bought Trilogy in 2010 for some $19.2 million, with $10 million upfront and $9.2 million in cash and scrip based on earn-out targets.

In July the company appointed Australian distributor McPherson's Consumer Products and its goods are now sold in independent pharmacies and major retail chains such as Priceline and Chemist Warehouse. The company earns 82 percent of its revenue from the Australian and New Zealand markets.

In the six months, the Ecoya brand candle unit probably boosted sales 9 percent, and is expected to be "just above breakeven", from a loss of $700,000 the previous year. Its Trilogy skincare brand is seen increasing Australian sales 24 percent and is expected to exceed budget, the company said.

Trilogy said it will provide an overview of the 2014 year and more detail on the first half at its annual general meeting in Auckland on Sept. 23.

Shares of the company were unchanged at 66 cents, and have gained 1.5 percent since the start of the year.

 

 

 

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors